Form 4 filed by Collins Helen Louise
Collins Helen Louise filed this Form 4 on ELVN (Enliven Therapeutics, Inc.) with 4 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-19 22:07:34 UTC.
- Accession
- 0001701247-26-000015
- Filer
- CIK 1701247
- Filed
- 2026-11-19
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: ELVN · Enliven Therapeutics, Inc. (CIK 1672619)
- Collins Helen Louise officer (CHIEF MEDICAL OFFICER)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-17 | M exercised | +5,000 | $2.48 | 30,000 | D |
| Common Stock | 2026-11-17 | S sold | -4,939 | $46.8313 | 25,061 | D |
| Common Stock | 2026-11-17 | S sold | -61 | $47.5954 | 25,000 | D |
| Stock Option (right to buy) derivative | 2026-11-17 | M exercised | -5,000 | $0 | 96,268 | D |